Organon (OGN) Gross Profit (2020 - 2026)

Organon (OGN) has reported Gross Profit for 7 consecutive years, with $783.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit fell 6.9% year-over-year to $783.0 million; the TTM figure through Mar 2026 stood at $3.3 billion (down 9.56% YoY), while the FY2025 annual figure was $3.3 billion, down 10.82% from the prior year.
• Gross Profit came in at $783.0 million for Q1 2026 at Organon, up from $741.0 million in the prior quarter.
• The five-year high for Gross Profit was $1.0 billion in Q1 2022, with the low at $741.0 million in Q4 2025.
• Average Gross Profit over 5 years is $908.2 million, with a median of $915.0 million recorded in 2023.
• Across the five-year window, Gross Profit grew 9.95% in 2022 and dropped 17.3% in 2025, its largest moves.
• Year by year, Gross Profit stood at $891.0 million in 2022, then gained by 2.69% to $915.0 million in 2023, then declined by 2.08% to $896.0 million in 2024, then declined by 17.3% to $741.0 million in 2025, then grew by 5.67% to $783.0 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $783.0 million, $741.0 million, and $857.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.